BeOne Medicines Expands BRUKINSA Access for CLL Patients
SAN CARLOS, Calif. & SEATTLE, Aug. 18, 2026 BeOne Medicines Ltd., together with the BeOne Care Foundation and The...
Global Health
Advertisement
GHIT Fund Accelerates Portable Ebola Diagnostic Innovation
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
Akagera Medicines Reports Positive Phase 1 AKG-100 Results
KIGALI, Rwanda, July 20, 2026 Akagera Medicines, Inc. has announced positive first-in-human Phase 1 results for AKG-100, its investigational...
PleoPharma Launches Phase 3 Trial for Cannabis Withdrawal
PHOENIXVILLE, Pa., June 20, 2026 PleoPharma, Inc. has announced the dosing of the first patient in CAN-004, its pivotal...
New Gates Foundation Grant Fuels Replicate’s Fight Against Tuberculosis
SAN DIEGO, Calif., June 20, 2026 Replicate Bioscience has secured a $3 million research grant from the Gates Foundation...
Advertisements
RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak
TEL AVIV, Israel and RALEIGH, N.C., June 2, 2026 RedHill Biopharma has announced efforts to advance the clinical development...
Soligenix Advances Bundibugyo Ebola Vaccine Platform
PRINCETON, New Jersey, May 26, 2026 Soligenix, Inc. has announced that its proprietary ThermoVax® vaccine platform may provide a...
WuXi Vaccines Receives ANVISA GMP Approval for Dengue Vaccine
SUZHOU, China, May 26, 2026 WuXi Vaccines, a wholly owned subsidiary of WuXi Biologics specializing in vaccine Contract Development...
Şahin and Türeci Honored for Vaccine Innovation
WASHINGTON, May 13, 2026 The Sabin Vaccine Institute honored renowned vaccine researchers Professor Uğur Şahin and Professor Özlem Türeci...
Novartis Coartem Baby Wins WHO Nod for Infant Malaria
BASEL, Switzerland, April 24, 2026 Novartis has achieved a major global health milestone as the World Health Organization (WHO)...
Advertisement
